Artifactual hypoglycaemia during treatment with filgrastim (rHu-met-G- CSF)

European Journal of Cancer Part A

Volumn 33, Issue 9, 1997, Pages 1520-

  Illarramendi, J J ^a   Iruin, A ^a   Mitxelena, I ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

DISEASE ASSOCIATION; DRUG SAFETY; HYPOGLYCEMIA; LETTER; LEUKOCYTOSIS; METABOLIC DISORDER; PATIENT MONITORING; PRIORITY JOURNAL; STOMACH CARCINOMA;

EID: 0030773489     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00191-3     Document Type: Letter

References (5)

1. G Decoster W Rich SL Brown Safety profile of filgrastim (r-metHuG-CSF) G Morstyn TM Dexter Filgrastim (r-metHuG-CSF) in Clinical Practice 1994 Marcel Dekker New York 267 290
2. JA Claspy DW Golde Granulocyte colony-stimulating factor (G-CSF): preclinical and clinical studies Semin Oncol 19 1992 386 394
3. H Wilke P Preusser U Fink High dose folinic acid, etoposide and 5-fluorouracil in advanced gastric cancer. A phase II study in elderly patients or patients with cardiac risk Invest New Drugs 8 1990 65 70
4. JB Field Hypoglycaemia Endocrinol Metab Clin North Am 18 1989 27 43
5. JR Astles WP Petros WP Peters FA Sedor Artifactual hypoglycaemia associated with hematopoietic cytokines Arch Pathol Lab Med 119 1995 713 716